Recent Posts in Venous thromboembolism Category
Posted on Apr 26, 2012 By Jennifer Williams
Bloomberg news reported today that Bayer announced it has settled 651 cases alleging that its birth control pills, Yaz and Yasmin, caused sometimes-fatal blood clots that can lead to deep vein ...
Continue reading "Yaz/Yasmin Settlements Grow to $142 Million" »
Posted on Apr 17, 2012 By Jennifer Williams
Last week Bloomberg news reported that Bayer AG, Germany's largest drugmaker, has agreed to pay at least $100 million to settle about 500 lawsuits involving Bayer's oral birth control pills, ...
Continue reading "Bayer Reportedly Settled 500 Yaz / Yasmin Lawsuits" »
Posted on Apr 10, 2012 By Jackson Allen Williams, LLP
The FDA announced to today that the drug labels for drosperinone-containing birth control pills, including Yasmin and Yaz, will be changed to include warnings regarding the increased risk of blood ...
Continue reading "FDA Announces Label Change for Yasmin and Yaz" »
Posted on Nov 21, 2011 By Jennifer Williams
An article out today on Bloomberg.com states that units of Bayer AG, Germany's largest drug maker, may have promoted its birth control pills, Yasmin and Yaz, for unapproved uses. The article also ...
Continue reading "New Article Suggests Bayer May Have Promoted Yaz/Yasmin for Unapproved Use" »
Posted on Nov 8, 2011 By Jennifer Williams
A new study published November 6, 2011 in the Canadian Medical Association Jounral links oral contraceptives containing drospirenone (Yaz, Yasmin, Ocella, Beyaz) with a higher risk of venous ...
Continue reading "New Study of Irsaeli Women Reveals Increased Risk of DVT and Pulmonary Embolism in Yaz/Yasmin Users" »
Posted on Oct 27, 2011 By Jennifer Williams
The FDA released the report today from its study of the relative risks of various combined hormonal contraceptives (CHCs). The study compared recently marketed CHCs including Yasmin/Yaz, Ortho Evra ...
Continue reading "Report from FDA-funded study confirms increased risk of VTEs in users of Yasmin and Yaz" »
Posted on Oct 26, 2011 By Allen Law Firm
A new study published in the British Medical Journal today confirms previous studies that concluded users of Yaz and Yasmin are at least at twice the risk of venous thromboembolism compared with users ...
Continue reading "New Danish Study Confirms Increased Risk of Venous Thromboembolism in Yaz / Yasmin Users" »
Posted on Sep 27, 2011 By Jennifer Williams
On September 26, 2011 the FDA issued a Drug Safety Communication regarding its safety review of drospirenone-containing oral contraceptives such as Yasmin and Yaz. The FDA bulletin states that while ...
Continue reading "FDA to Convene Panel to Weigh Risks of Yasmin and Yaz" »
Posted on Jun 14, 2011 By Jennifer Williams, Esq.
On June 9, 2011, Judge Herndon set the bellwether trial schedule for the Yaz / Yasmin litigation in the federal court multidistrict litigation (MDL). The first case set for trial involves a young ...
Continue reading "MDL Bellwether Trial Schedule Set" »
Posted on Apr 25, 2011 By Jackson Allen Williams, LLP
April 25, 2011 - Two articles published in British Medical Journal over the weekend confirm previous studies that show an increased risk of venous thromboembolic events including stroke , pulmonary ...
Continue reading "Two New Articles Confirm Increased Risk of Venous Thromboembolism in Yaz & Yasmin Users" »
Posted on Jan 7, 2011 By Yaz Lawyers
The Pennsylvania State Court Judge Sandra Moss overseeing the consolidated litigation involving Yaz and Yasmin birth control pills has established a bellwether trial schedule similar to the one ...
Continue reading "Bellwether Trial Schedule Established for Yaz, Yasmin Cases in Pennsylvania" »
Posted on Dec 6, 2010 By Allen Law Firm
As previously reported, the first "bellwether" case in the Yaz / Yasmin Multi-District Litigation will involve a woman who suffered a pulmonary embolism . Because so many of the women who have sued ...
Continue reading "First Yaz Case Will Involve Pulmonary Embolism" »
Posted on Nov 15, 2010 By Jackson Allen Williams, LLP
Members of the Plaintiffs Steering Committee and Defendants Steering Committee have chosen the first twenty-four Yaz/Yasmin cases from which the first bellwether trials will be chosen. Plaintiffs and ...
Continue reading "Preliminary Yaz/Yasmin Bellwether Case Selections Completed" »
Posted on Oct 13, 2010 By Jennifer Williams
The Judge overseeing the Yaz / Yasmin multidistrict litigation has ordered that the first Yaz/Yasmin lawsuit go to trial beginning September 12, 2011. The Court's order detailed the process for ...
Continue reading "First Yaz Case to Trial September 12, 2011" »
Posted on Aug 3, 2010 By Jennifer Williams
A study published in the Annals of Internal Medicine on Monday found that clinical trials for drugs are more likely to show positive results when they are funded by the pharmaceutical industry. ...
Continue reading "New Report Shows Industry Funded Studies More Likely to Have Positive Outcome" »
Posted on Jul 29, 2010 By Jennifer Williams
In the last two months alone, over 700 Yasmin / Yaz lawsuits have been filed in the federal multidistrict Yaz litigation. That brings the total number of Yasmin / Yaz lawsuits filed in federal court ...
Continue reading "Number of Yaz, Yasmin, Ocella, Gianvi Lawsuits Continues to Grow" »
Posted on Apr 16, 2010 By Jennifer Williams
On April 9, 2010, a press release from Bayer stated it will update the labels for Yaz and Yasmin. The statement from Bayer indicates that the FDA has approved the new labels for Yaz and Yasmin. The ...
Continue reading "Bayer Updates Labels for Yaz and Yasmin" »
Posted on Oct 22, 2009 By Allen Law Firm
October 22, 2009 - Swissmedic , the Swiss Agency for Therapeutic Products, released its report regarding the increased risk of thromboembolism for Yaz and Yasmin users. Swissmedic's Human Medicines ...
Continue reading "Swissmedic Releases Report on Venous Thromboembolism Caused by Yaz and Yasmin" »